Peregrine Capital Management LLC Vertex Pharmaceuticals Inc Transaction History

Peregrine Capital Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 03, 2021	SELL	$187.49 - $221.1 $31.6 Million - $37.3 Million	-168,790 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$207.02 - $241.31 $2.52 Million - $2.94 Million	12,168 Added 7.77%	168,790 $36.3 Million
Q4 2020 Jan 19, 2021	BUY	$207.01 - $276.09 $4.09 Million - $5.45 Million	19,742 Added 14.42%	156,622 $37 Million
Q3 2020 Oct 20, 2020	BUY	$255.65 - $303.1 $229,062 - $271,577	896 Added 0.66%	136,880 $37.2 Million
Q2 2020 Jul 30, 2020	BUY	$225.48 - $295.8 $972,044 - $1.28 Million	4,311 Added 3.27%	135,984 $39.5 Million
Q1 2020 Apr 17, 2020	BUY	$199.77 - $247.81 $206,162 - $255,739	1,032 Added 0.79%	131,673 $31.3 Million
Q4 2019 Jan 16, 2020	BUY	$166.71 - $223.91 $83,021 - $111,507	498 Added 0.38%	130,641 $28.6 Million
Q3 2019 Oct 16, 2019	BUY	$166.23 - $187.09 $2.88 Million - $3.24 Million	17,324 Added 15.36%	130,143 $22 Million
Q1 2019 Apr 12, 2019	BUY	$163.73 - $194.7 $219,561 - $261,092	1,341 Added 1.2%	112,819 $0
Q4 2018 Jan 17, 2019	BUY	$151.91 - $192.21 $2.07 Million - $2.61 Million	13,601 Added 13.9%	111,478 $18.5 Million
Q2 2018 Jul 12, 2018	BUY	$145.72 - $169.96 $3.12 Million - $3.64 Million	21,430 Added 28.03%	97,877 $0
Q1 2018 Apr 16, 2018	BUY	$151.6 - $177.13 $11.6 Million - $13.5 Million	76,447 New	76,447 $0

1,725

221M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Peregrine Capital Management LLC with notifications on news.